SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) -- Ignore unavailable to you. Want to Upgrade?


To: Walter Morton who wrote (245)6/22/1999 11:24:00 AM
From: Scott Ozer  Read Replies (1) | Respond to of 513
 
What was the point of that? Avan has 10% of its shares held by institutions, a very important fact if this keep growing. Where is the 10 dollars per share in cash? Please explain yourself.